Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05650359 · ClinicalTrials.gov registry record · NA
Study of the Use of Orthopulse Photobiomodulation
A NA study of Orthodontics, sponsored by Biolux Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT05650359: Recruiting NA study of Orthodontics, sponsored by Biolux Technology.
NCT05650359 is a NA study of Orthodontics that is actively recruiting participants, run by Biolux Technology. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05650359, a NA study of Orthodontics, is actively recruiting participants, sponsored by Biolux Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This PMCF study evaluates the safety and performance of OrthoPulse photobiomodulation to accelerate tooth movement during alignment with fixed appliances.
Primary Outcome
The primary endpoint of this PMCF study is the rate of tooth alignment as per Little's irregularity index LII (measured as the distance of linear displacement in mm divided by a unit of time between the lower arch anterior 6 teeth) during the time between baseline and 42 days after start of treatment.
Conditions Studied
Interventions
- OTHER No intervention
- DEVICE OrthoPulse
Study Locations (1)
Arizona
- Private Practice - Chandler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2022-10-13 |
| Est. Completion | 2028-05-15 |
| Phase | NA |
What NCT05650359 shows while recruiting
NCT05650359 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Orthodontics appearing as the primary indexed condition, and to 2 interventions - of which No intervention is the first listed.
NCT05650359 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05650359 about?
NCT05650359 is a clinical study titled "Study of the Use of Orthopulse Photobiomodulation". This PMCF study evaluates the safety and performance of OrthoPulse photobiomodulation to accelerate tooth movement during alignment with fixed appliances.
What is the current status of trial NCT05650359?
This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2022-10-13. Estimated completion is 2028-05-15.
What conditions does trial NCT05650359 study?
This clinical trial studies the following conditions: Orthodontics.
What interventions are being tested in trial NCT05650359?
The interventions under investigation include: No intervention (OTHER), OrthoPulse (DEVICE).
Who is sponsoring clinical trial NCT05650359?
This trial is sponsored by Biolux Technology, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05650359 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Orthodontics
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05650359's enrollment target sits among peer trials
42 1437th of 2000 higher than 555 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI